Patents by Inventor Isabelle Chemin

Isabelle Chemin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Primate model from the family cercopithecidae infected by a HBV strain of human genotype
    Patent number: 9247720
    Abstract: The invention relates to a non-human primate animal model for HBV infection, said animal model being of the Cercopithecidae family.
    Type: Grant
    Filed: March 24, 2011
    Date of Patent: February 2, 2016
    Assignees: Institut National de la Santé et de la Recherche Médicale, Hospices Civils de Lyon, Université Claude Bernard Lyon 1
    Inventors: Isabelle Chemin, Christian Trepo
  • PRIMATE MODEL FROM THE FAMILY CERCOPITHECIDAE INFECTED BY A HBV STRAIN OF HUMAN GENOTYPE
    Publication number: 20130111612
    Abstract: The invention relates to a non-human primate animal model for HBV infection, said animal model being of the Cercopithecidae family.
    Type: Application
    Filed: March 24, 2011
    Publication date: May 2, 2013
    Inventors: Isabelle Chemin, Christian Trepo
  • HXHV virus, nucleic material, peptide material and uses
    Patent number: 7479386
    Abstract: Isolated HXHV virus having the following characteristics: (i) a DNA genome which is at least partially single-stranded, (ii) the said genome comprises one reading frame (ORF) encoding one protein or one polyprotein (iii) the said genome comprises a nucleotide sequence which exhibits, for any segment of at least 40 nucleotides belonging to the said sequence, at least 90% homology with SEQ ID NO: 1 or with its complementary sequence, nucleic material and peptide material and uses.
    Type: Grant
    Filed: December 27, 2002
    Date of Patent: January 20, 2009
    Assignee: Institut National de la Recherche Medicale
    Inventors: Isabelle Chemin, Christian Trepo, Frederic Bedin, Colette Jolivet Reynaud
  • Nucleic and Protein Sequences from the Hxhv Virus and Uses Thereof
    Publication number: 20080102077
    Abstract: The disclosure relates to isolated nucleic acid sequences obtainable from the genome of the HXHV virus, specifically, nucleic acid sequences comprising the sequence identified by SEQ ID NO: 4 or the complementary sequence to SEQ ID NO: 4, and to polypeptides coded by the nucleic acid sequences and uses thereof.
    Type: Application
    Filed: July 5, 2004
    Publication date: May 1, 2008
    Applicant: Institut National de la Sante et de la Recherche Medicale (I.N.S.E.R.M.)
    Inventors: Isabelle Chemin, Christian Trepo
  • Hxhv virus, nucleic material, peptide material and uses
    Publication number: 20050037336
    Abstract: Isolated HXHV virus having the following characteristics: (i) a DNA genome which is at least partially single-stranded, (ii) the said genome comprises one reading frame (ORF) encoding one protein or one polyprotein (iii) the said genome comprises a nucleotide sequence which exhibits, for any segment of at least 40 nucleotides belonging to the said sequence, at least 90% homology with SEQ ID NO: 1 or with its complementary sequence, nucleic material and peptide material and uses.
    Type: Application
    Filed: December 27, 2002
    Publication date: February 17, 2005
    Inventors: Isabelle Chemin, Christian Trepo, Frederic Bedin, Colette Jolivet Reynaud
  • Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof
    Publication number: 20030129202
    Abstract: The invention concerns an isolated mHBV having the following characteristics: (i) a genome with partly double-strand circular DNA, (ii) the genome including the Pre-S, S, C, P and X genes, (iii) the Pre-S genes coding for surface antigens, the S gene coding for a HBsAg envelope protein, the C gene coding for a HBeAg protein and aHBcAg protein, the P gene coding for a DNA reverse polymerase/transcriptase enzyme and the X gene coding for a HBxAg protein. The invention is characterised in that the gene S comprises a DNA nucleotide sequence referenced SEQ ID NO 1 and the Pre-S gene comprises a nucleotide sequence referenced SED ID NO 3. The invention also concerns DNA molecule, RNA molecule, modified surface proteins and their uses in particular for diagnostic, therapeutic and vaccine purposes.
    Type: Application
    Filed: December 16, 2002
    Publication date: July 10, 2003
    Inventors: Christian Trepo, Bernard Mandrand, Alan Kay, Isabelle Chemin, Florence Komurian-Pradel